Tag Archives: Oral

FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older

FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older Print this page WOBURN, Mass. (July 10, 2019) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, announced today that the U.S. Food and Drug Administration (FDA) has approved Katerzia (amlodipine)… Read More »

Omadacyline Now Available in IV, Oral Forms for CABP, ABSSSI

February 08, 2019 This article originally appeared here. Share this content: Paratek also announced the availability of 3 FDA-approved antimicrobial susceptibility tests. Paratek announced the launch of Nuzyra (omadacycline) for the treatment of adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). It is the first once-daily antibiotic approved to… Read More »

Oral Appliance Therapy – All You Ought to Know

Obstructive sleep apnea is a sleep disorder where a person stops breathing periodically due to collapsing soft tissue in the airway throughout the night. These stops in breathing usually last for around ten seconds and are often followed by snorts, gasps, or choking sounds as a person’s body fights to resume breathing again. The obstructive… Read More »